(Q45368415)

English

Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation

scientific article published in March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation (English)

1 reference

Europe PubMed Central

13 December 2017

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

13 December 2017

8

object named as

Peter Neuhaus

1 reference

Europe PubMed Central

13 December 2017

10

object named as

Marcus Bahra

1 reference

Europe PubMed Central

13 December 2017

author name string

Dennis Eurich

1

1 reference

Europe PubMed Central

13 December 2017

Sabine Boas-Knoop

2

1 reference

Europe PubMed Central

13 December 2017

Martin Ruehl

3

1 reference

Europe PubMed Central

13 December 2017

Maria Schulz

4

1 reference

Europe PubMed Central

13 December 2017

Esperanza D Carrillo

5

1 reference

Europe PubMed Central

13 December 2017

Ruth Neuhaus

7

1 reference

Europe PubMed Central

13 December 2017

Ulf Peter Neumann

9

1 reference

Europe PubMed Central

13 December 2017

publication date

1 March 2011

1 reference

Europe PubMed Central

13 December 2017

Liver Transplantation

1 reference

Europe PubMed Central

13 December 2017

17

1 reference

Europe PubMed Central

13 December 2017

3

1 reference

Europe PubMed Central

13 December 2017

289-298

1 reference

Europe PubMed Central

13 December 2017

[Chronic HCV infections. A model disease for therapy, economics and social-medical aspects]

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Genomics: Hepatitis C virus gets personal

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Treating hepatitis C infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Antiviral treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Hepatitis C and liver fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

The association between hepatitis C infection and survival after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Histological and clinical outcome after liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Impact of immunosuppressive therapy on recurrence of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Early high peak hepatitis C viral load levels independently predict hepatitis C-related liver failure post-liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Lambda interferon inhibits hepatitis B and C virus replication

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Interferon type I gene expression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by C-methionine breath test

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1002%2FLT.22235

21 January 2018

Identifiers

10.1002/LT.22235

1 reference

Europe PubMed Central

13 December 2017

release_d5kc5o66dfbw7eoahyjrwnz7ai

1 reference

https://api.fatcat.wiki/v0/release/d5kc5o66dfbw7eoahyjrwnz7ai

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45368415&oldid=2075908071"